294 related articles for article (PubMed ID: 31039173)
1. Allele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolism.
Howard AD; Wang X; Prasad M; Sahu AD; Aniba R; Miller M; Hannenhalli S; Chang YC
PLoS One; 2019; 14(4):e0215911. PubMed ID: 31039173
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
3. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
Chen CY; Chang IS; Hsiung CA; Wasserman WW
BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
[TBL] [Abstract][Full Text] [Related]
4. Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels.
Cavalli M; Pan G; Nord H; Wadelius C
Lipids Health Dis; 2016 Jan; 15():18. PubMed ID: 26817450
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract][Full Text] [Related]
6. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
7. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
Abd El-Aziz TA; Mohamed RH; Hagrass HA
J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
[TBL] [Abstract][Full Text] [Related]
9. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
[TBL] [Abstract][Full Text] [Related]
10.
Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regions.
Lutz MW; Chiba-Falek O
Alzheimers Dement (N Y); 2022; 8(1):e12244. PubMed ID: 35229021
[TBL] [Abstract][Full Text] [Related]
12. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive functional annotation of seventy-one breast cancer risk Loci.
Rhie SK; Coetzee SG; Noushmehr H; Yan C; Kim JM; Haiman CA; Coetzee GA
PLoS One; 2013; 8(5):e63925. PubMed ID: 23717510
[TBL] [Abstract][Full Text] [Related]
14. Identification of an IL-6 response element in the human LCAT promoter.
Feister HA; Auerbach BJ; Cole LA; Krause BR; Karathanasis SK
J Lipid Res; 2002 Jun; 43(6):960-70. PubMed ID: 12032172
[TBL] [Abstract][Full Text] [Related]
15. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol.
Khetarpal SA; Edmondson AC; Raghavan A; Neeli H; Jin W; Badellino KO; Demissie S; Manning AK; DerOhannessian SL; Wolfe ML; Cupples LA; Li M; Kathiresan S; Rader DJ
PLoS Genet; 2011 Dec; 7(12):e1002393. PubMed ID: 22174694
[TBL] [Abstract][Full Text] [Related]
16. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
[TBL] [Abstract][Full Text] [Related]
17. Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT.
Bochem AE; Holleboom AG; Romijn JA; Hoekstra M; Dallinga GM; Motazacker MM; Hovingh GK; Kuivenhoven JA; Stroes ES
PLoS One; 2014; 9(5):e90967. PubMed ID: 24842300
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
19. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks.
Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
Atherosclerosis; 2005 Dec; 183(2):199-212. PubMed ID: 15935359
[TBL] [Abstract][Full Text] [Related]
20. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
